Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Meinolf Karthaus, Peter Reichardt, H. Kröning et al.|Annals of Oncology|2005

Cited by 223